Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Covance by Labcorp
483
•Covance by Labcorp•May 20, 2021

FDA 483 - Covance by Labcorp - May 20, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents
Record Details

An FDA inspection of Covance by Labcorp in Durham, NC, a Contract Research Organization, revealed a failure to ensure proper monitoring of a clinical study. Approximately 100 protocol deviations, some deemed "important," were not identified in a timely manner. These issues impacted subject safety, regulatory compliance, and data integrity.

Company
Covance by Labcorp
Inspection Date
May 20, 2021
Product Type
Drugs
Office
Atlanta District Office
Person
  • Betsy C. Galliher
Open in Dashboard

ID · 7a6bfe64-9576-4295-abd3-9eee9a8b41af

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.